Keynote Speakers
Amy Shen Professor and Provost, Okinawa Institute of Science and Technology Graduate University |
Emmanuel Delamarche Manager Precision Diagnostics, IBM Research - Zürich |
Robert Vries CEO, HUB Organoids |
Valérie Taly CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité |
Regina Luttge Professor, Eindhoven University of Technology |
Lorena Diéguez Leader of the Medical Devices Research Group, INL- International Iberian Nanotechnology Laboratory |
OverviewSelectBIO Point-of-Care, Biosensors & Mobile Diagnostics Europe 2020 brings
together the key opinion leaders from both academia and industry, this
annual conference will discuss the expanding Point-of-Care Diagnostics
and Wearables fields and provide the most up-to-date presentations
from leaders in these fields and offer networking and engagement
opportunities with delegates from around the world. This
conference will provide an overview of the point-of-care (POC) testing
landscape, from novel technologies to regulatory approval. The aim of this meeting is to bring together life science
researchers that work at the interface between biology and chemistry and
technology development to discuss problems, highlight solutions and
facilitating collaborations. Emphasis will be placed on mobile diagnostics platforms including wearables and other mobile platforms and convergence with microfluidics-based and lab-on-a-chip approaches. Registered conference delegates have access to the co-located parallel conference tracks: - Lab-on-a-Chip and Microfluidics Europe 2020
- Organ-on-a-Chip, Tissue-on-a-Chip & Organoids Europe 2020
- Point-of-Care, Biosensors & Mobile Diagnostics Europe 2020
This conference was originally scheduled for June 23-24, 2020 but has been moved to September 9-10, 2020 due to the global coronavirus pandemic. The conference will be run in a hybrid format with a physical event in Rotterdam complemented with virtual presentations from speakers around the world who are unable to attend the event in person. Physical conference takes place at the Hilton Rotterdam.
SelectBIO Conference Safety Guidelines Relating to COVID-19
Agenda Topics- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- Next Generation Technologies for Pathogen Detection
- Rapid Biodetection of Pathogens and Threat Identification
- Wearable and Implantable Devices and Mobile Diagnostics Platforms/Devices
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateMark Bradley, Professor of Therapeutic Innovation, Precision Healthcare University Research Institute, Queen Mary University of London John Brennan, Professor and Director, Biointerfaces Institute, McMaster University Francesco Dal Dosso, Innovation Manager, KU Leuven Vincent Linder, Founder and President, CDP BioMedical Consulting and CEO at Calciscon AG Menno Prins, Professor, Eindhoven University of Technology & Helia BioMonitoring Jean-Manuel Segura, Professor, University of Applied Sciences and Arts Western Switzerland Valais Annemarijn Steijlen, Researcher, Delft University of Technology
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|